Published date:Feb 21 2018

Journal Title: KnE Engineering

Issue title: XIII International Youth Scientific and Practical Conference "FUTURE OF ATOMIC ENERGY - AtomFuture 2017"

Pages:309-316

DOI: 10.18502/keg.v3i3.1630

Nasedkina N.V.

Beketov E.E.

Isaeva E.V.

Malakhov E.P.

Golovanova O.Y.

Ulyanenko L.N.

Chernukha A.E.

Saburov V.O.

Lepilina O.G.

Ulyanenko S.Е.

The study was aimed to the biological effectiveness of the proton scanning beam of the first Russian medical facility. The clonogenic assay of B-16 tumor cells was used as a test system. Cell irradiation was carried out in a suspension condition in a water phantom. Single and three-field exposures were studied. The dose interval was 2-8 Gy. The energy range from 47.5 to 92.0 MeV was used for the Bragg peak formation. The relative biological effectiveness of protons comparing to gamma-rays was 1.2 for single-field and 1.5 for three-field irradiation. The results obtained agree with literature data related to the used cell culture (B-16) and linear energy transfer range (3÷8 keV/µm).

[1] Kaprin A.D., Galkin V.N., Zhavoronkov L.P., et al. Synthesis of fundamental and applied research is the basis for ensuring a high level of scientific results and their introduction into medical practice.// Radiation and Risk. – 2017. – Т. 26. –N. 2. – P. 26-40.


[2] Beketov E., Isaeva E., Koryakin S., et al. The study of biological effectiveness of U70 accelerator carbon ions using melanoma B-16 clonogenic assay. // Rad. Applic. – 2017. – V. 2. – I. 2. – P.90-93.


[3] Cuaron J.J, Chang C., Lovelock M., et al. Exponential increase in relative biological effectiveness along distal edge of a proton Bragg peak as measured by deoxyribonucleic acid double-strand breaks. // Int J Radiat Oncol Biol Phys. – 2016. – V.95. – I.1. –P.62-69.


[4] Friedrich T., Scholz U., Elsässer T., et al. Systematic analysis of RBE and related quantities using a database of cell survival experiments with ion beam irradiation. // J Radiat Res. – 2013. – 54. – I. 3. – P. 494-514.


[5] Giovannini G., Bohlen T., Cabal G., et al. Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios. // Radiat Oncol. –2016. – V.11. – P. 68.


[6] Grassberger C, Paganetti H. Varying relative biological effectiveness in proton therapy: knowledge gaps versus clinical significance.// Acta Oncol. –2017. – V.56. – I.6. –P.761-762.


[7] Hall E. Protons for radiotherapy: a 1946 proposal.//Lancet Oncol. –2009. – V.10. – I.2. –P.196.


[8] Ibanez I., Bracalente C., Molinari B., et al. Induction and Rejoining of DNA Double Strand Breaks Assessed by H2AX Phosphorylation in Melanoma Cells Irradiated with Proton and Lithium Beams. // Int J Radiat Oncol Biol Phys. –2009. – V.74. – I. 4. – P. 1226-1235.


[9] Jones B. Towards achieving the full clinical potential of proton therapy by inclusion of LET and RBE models. Cancers (Basel). – 2015. – V.7. – I.1. –P.460-480.


[10] Keta O., Todorovic D., Popovic N., et al. Radiosensitivity of human ovarian carcinoma and melanoma cells to γ-rays and proton. // Arch Med Sci. – 2014. – V.10. – I.3. – P.578-586.


[11] Maeda K., Yasui H., Matsuura T., et al. Evaluation of the relative biological effectiveness of spot-scanning proton irradiation in vitro. // J Radiat Res. – 2016. – V.57. – I.3. – P.307-311.


[12] Marshall T.I., Chaudhary P., Michaelidesova A., et al. Investigating the implications of a variable RBE on proton dose fractionation across a clinical pencil beam scanned spread-out Bragg peak. // Int J Radiat Oncol Biol Phys. – 2016. – V.95. – I.1. – P.70-77.


[13] Matsumoto Y., Matsuura T., Wada M., et al. Enhanced radiobiological effects at the distal end of a clinical proton beam: in vitro study. // Journal of Radiation Research.– 2014. – V.55. – I. 4. –P.816-822.


[14] Michaelidesova А., Vachelova J., Puchalska M., et al. Relative biological effectiveness in a proton spread-out Bragg peak formed by pencil beam scanning mode. // Australas Phys Eng Sci Med. – 2017. – V.40. – I. 2. –P.359-368.


[15] Paganetti H. Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoints, dose, and linear energy transfer. // Phys Med Biol. – 2014. – V.59. – I.22. – P.4194-4272.


[16] Particle Therapy Centers [Internet]. Particle Therapy Co-Operative Group [cited 2017 Nov 3]. Available from: https://www.ptcog.ch/.


[17] Slonina D., Biesaga B., Swakon J., et al. Relative biological effectiveness of the 60- MeV therapeutic proton beam at the Institute of Nuclear Physics (IFJ PAN) in Krakow, Poland. // Radiat Environ Biophys. – 2014. – V.53. – I.4. – P.745-754.


[18] Tommasino F, Durante M. Proton Radiobiology. // Cancers. – 2015. – V.7. –P.353-381.